The dihydropyrimidine dehydrogenase gene contributes to heritable differences in sleep in mice - PubMed (original) (raw)
The dihydropyrimidine dehydrogenase gene contributes to heritable differences in sleep in mice
Brendan T Keenan et al. Curr Biol. 2021.
Abstract
Many aspects of sleep are heritable, but only a few sleep-regulating genes have been reported. Here, we leverage mouse models to identify and confirm a previously unreported gene affecting sleep duration-dihydropyrimidine dehydrogenase (Dpyd). Using activity patterns to quantify sleep in 325 Diversity Outbred (DO) mice-a population with high genetic and phenotypic heterogeneity-a linkage peak for total sleep in the active lights off period was identified on chromosome 3 (LOD score = 7.14). Mice with the PWK/PhJ ancestral haplotype at this location demonstrated markedly reduced sleep. Among the genes within the linkage region, available RNA sequencing data in an independent sample of DO mice supported a highly significant expression quantitative trait locus for Dpyd, wherein reduced expression was associated with the PWK/PhJ allele. Validation studies were performed using activity monitoring and EEG/EMG recording in Collaborative Cross mouse strains with and without the PWK/PhJ haplotype at this location, as well as EEG and EMG recording of sleep and wake in Dpyd knockout mice and wild-type littermate controls. Mice lacking Dpyd had 78.4 min less sleep during the lights-off period than wild-type mice (p = 0.007; Cohen's d = -0.94). There was no difference in other measured behaviors in knockout mice, including assays evaluating cognitive-, social-, and affective-disorder-related behaviors. Dpyd encodes the rate-limiting enzyme in the metabolic pathway that catabolizes uracil and thymidine to β-alanine, an inhibitory neurotransmitter. Thus, data support β-alanine as a neurotransmitter that promotes sleep in mice.
Keywords: Collaborative Cross; Diversity Outbred; Dpyd; dihydropyrimidine dehydrogenase; genetics; knockout; mice; sleep.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests A.I.P. is The John L. Miclot Professor of Medicine at the University of Pennsylvania; funds for this endowment were provided by the Philips Respironics Foundation. G.A.C., E.J.C., and K.L.S. disclose that The Jackson Laboratory produces and sells a wide variety of mice for research, including Collaborative Cross and Diversity Outbred mice. The other authors declare no competing interests.
Figures
Figure 1.. Allele effects at the LOD peak for total sleep during lights off in DO mice.
Founder-specific additive genetic effects on total sleep during lights off are shown in the linkage region identified on chromosome 3 (top panel). The 95% Bayesian credible interval (118.4-122.6 Mb) is denoted with black dashed lines. Colored lines illustrate the relative change in total sleep duration attributable to each of the founder haplotypes, with lines below zero indicating a reduction in total sleep and lines above zero indicating increased total sleep. A large relative reduction in sleep is observed for the PWK/PhJ haplotype (red) in this region, with the NOD haplotype associated with increased sleep (dark blue). LOD scores across the region are shown in the bottom panel. See Figure S1 for candidate genes under LOD peak.
Figure 2.. Expression of Dpyd in the hippocampus of DO mice.
Founder-specific additive genetic effects on Dpyd expression from RNA sequencing of the hippocampus in an independent sample of DO mice are shown in the top panel. There is a marked reduction in Dpyd expression associated with the PWK/PhJ haplotype at our linkage region of interest, with a LOD score >20. This PWK/PhJ-specific reduction in Dpyd expression is similar to the association seen for total sleep duration during lights off, leading to the selection of Dpyd as the likely causal gene under the linkage peak. Figure and data are available through the online DO Hippocampus QTL Viewer (
https://churchilllab.jax.org/qtlviewer/DO/hippocampus
). See Figure S1 for founder effects for expression of all genes within the linkage region.
Figure 3.. Comparison of total sleep during lights off in Collaborative Cross strains with relevant founder Dpyd alleles.
Figure 3A illustrates total sleep during lights off based on high-throughput phenotyping using beam breaks in Collaborative Cross strains with founder Dpyd alleles. There was a significant difference among strains (p=0.005), including differences between the black (CC003/Unc) and white (CC009/Unc) PWK/PhJ Dpyd strains and both the NOD/ShiLtJ (p=0.006 and 0.008, respectively) and WSB/EiJ (p=0.025 and 0.032, respectively) strains. See Tables S1andS2 for additional phenotype comparisons. Figure 3B shows total sleep from EEG/EMG recording in 3-hour windows during lights off in the CC strains with PWK/PhJ (CC003/Unc) and NOD/ShiLtJ (CC004/TauUnc) Dpyd alleles. A moderately large difference on average was seen in total sleep over the entire lights off period, but this result did not reach statistical significance (p=0.240; Cohen’s d = −0.71). When examining the lights off period in more detail, significantly less sleep was observed in the PWK/PhJ Dpyd strain during the first 3 hours (7PM-10PM; 41.0±26.4 vs. 80.4±7.7 minutes; p=0.003; Cohen’s d = −2.03). See Tables S3andS4 for additional phenotype comparisons. Results presented as Mean (95% CI)
Figure 4.. EEG/EMG total sleep in lights off in male and female Dpyd knockout mice.
Total sleep during the lights off period is shown in Dpyd knockout (KO) mice and wildtype (WT) littermate controls, overall and stratified by sex. Among all mice, there was significantly reduced sleep in the knockout mouse (263.5±92.6 minutes) compared to the wildtype control (341.9±74.0 minutes; p=0.007). The impact of the knockout was similar in male and female mice (interaction p=0.689); statistical significance is impacted by lower sample size for sex-specific analyses. See Tables S6andS7 for additional phenotype comparisons. Sex x Genotype Interaction p=0.689 ∣ Data Presented as Mean (95% CI)
Similar articles
- Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene.
Kuilenburg ABPV, Meijer J, Tanck MWT, Dobritzsch D, Zoetekouw L, Dekkers LL, Roelofsen J, Meinsma R, Wymenga M, Kulik W, Büchel B, Hennekam RCM, Largiadèr CR. Kuilenburg ABPV, et al. Biochim Biophys Acta. 2016 Apr;1862(4):754-762. doi: 10.1016/j.bbadis.2016.01.009. Epub 2016 Jan 12. Biochim Biophys Acta. 2016. PMID: 26804652 - Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity.
Hamzic S, Schärer D, Offer SM, Meulendijks D, Nakas C, Diasio RB, Fontana S, Wehrli M, Schürch S, Amstutz U, Largiadèr CR. Hamzic S, et al. Br J Clin Pharmacol. 2021 Aug;87(8):3234-3243. doi: 10.1111/bcp.14742. Epub 2021 Mar 30. Br J Clin Pharmacol. 2021. PMID: 33491253 Free PMC article. - Translating DPYD genotype into DPD phenotype: using the DPYD gene activity score.
Henricks LM, Lunenburg CA, Meulendijks D, Gelderblom H, Cats A, Swen JJ, Schellens JH, Guchelaar HJ. Henricks LM, et al. Pharmacogenomics. 2015;16(11):1277-86. doi: 10.2217/pgs.15.70. Epub 2015 Aug 12. Pharmacogenomics. 2015. PMID: 26265346 Review. - Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.
Meulendijks D, Henricks LM, van Kuilenburg AB, Jacobs BA, Aliev A, Rozeman L, Meijer J, Beijnen JH, de Graaf H, Cats A, Schellens JH. Meulendijks D, et al. Cancer Chemother Pharmacol. 2016 Oct;78(4):875-80. doi: 10.1007/s00280-016-3137-0. Epub 2016 Aug 20. Cancer Chemother Pharmacol. 2016. PMID: 27544765
Cited by
- Investigating Neuron Degeneration in Huntington's Disease Using RNA-Seq Based Transcriptome Study.
Sneha NP, Dharshini SAP, Taguchi YH, Gromiha MM. Sneha NP, et al. Genes (Basel). 2023 Sep 14;14(9):1801. doi: 10.3390/genes14091801. Genes (Basel). 2023. PMID: 37761940 Free PMC article. - Into the Wild: A novel wild-derived inbred strain resource expands the genomic and phenotypic diversity of laboratory mouse models.
Dumont BL, Gatti DM, Ballinger MA, Lin D, Phifer-Rixey M, Sheehan MJ, Suzuki TA, Wooldridge LK, Frempong HO, Lawal RA, Churchill GA, Lutz C, Rosenthal N, White JK, Nachman MW. Dumont BL, et al. PLoS Genet. 2024 Apr 10;20(4):e1011228. doi: 10.1371/journal.pgen.1011228. eCollection 2024 Apr. PLoS Genet. 2024. PMID: 38598567 Free PMC article. - Rare Genetic Variants Provide Protection for Obstructive Sleep Apnea.
Pack AI, Keenan BT. Pack AI, et al. Am J Respir Crit Care Med. 2022 Nov 15;206(10):1199-1200. doi: 10.1164/rccm.202207-1414ED. Am J Respir Crit Care Med. 2022. PMID: 35904813 Free PMC article. No abstract available. - Synaptic dysfunction connects autism spectrum disorder and sleep disturbances: A perspective from studies in model organisms.
Doldur-Balli F, Imamura T, Veatch OJ, Gong NN, Lim DC, Hart MP, Abel T, Kayser MS, Brodkin ES, Pack AI. Doldur-Balli F, et al. Sleep Med Rev. 2022 Apr;62:101595. doi: 10.1016/j.smrv.2022.101595. Epub 2022 Jan 25. Sleep Med Rev. 2022. PMID: 35158305 Free PMC article. Review.
References
- Aguiar GF, da Silva HP, Marques N. Patterns of daily allocation of sleep periods: a case study in an Amazonian riverine community. Chronobiologia. 1991; 18 (1): 9–19. - PubMed
- Hur Y-M, Bouchard TJ Jr., Lykken DT. Genetic and environmental influence on morningness-eveningness. Personality and Individual Differences. 1998; 25 (5): 917–925.
- Vink JM, Groot AS, Kerkhof GA, Boomsma DI. Genetic analysis of morningness and eveningness. Chronobiol Int. 2001; 18 (5): 809–822. - PubMed
- Klei L, Reitz P, Miller M, et al. Heritability of morningness-eveningness and self-report sleep measures in a family-based sample of 521 hutterites. Chronobiol Int. 2005; 22 (6): 1041–1054. - PubMed
- Heath AC, Kendler KS, Eaves LJ, Martin NG. Evidence for genetic influences on sleep disturbance and sleep pattern in twins. Sleep. 1990; 13 (4): 318–335. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 HL094307/HL/NHLBI NIH HHS/United States
- U54 HD086984/HD/NICHD NIH HHS/United States
- R01 HL111725/HL/NHLBI NIH HHS/United States
- R01 HL134015/HL/NHLBI NIH HHS/United States
- R01 GM070683/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases